Cargando…
Temporal Trends and Factors Associated With Cardiovascular Drug Development, 1990 to 2012
Cardiovascular disease remains a leading cause of death, but stakeholders have recently raised concerns about the pace of innovation and investment in developing new therapeutics. Here, the authors characterized temporal trends in cardiovascular research and development over the past 2 decades and t...
Autores principales: | Hwang, Thomas J., Lauffenburger, Julie C., Franklin, Jessica M., Kesselheim, Aaron S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113354/ https://www.ncbi.nlm.nih.gov/pubmed/30167520 http://dx.doi.org/10.1016/j.jacbts.2016.03.012 |
Ejemplares similares
-
Overcoming Barriers to Development of Novel Therapies for Cardiovascular Disease: Insights From the Oncology Drug Development Experience
por: Khakoo, Aarif Y., et al.
Publicado: (2019) -
Regulatory Solutions to the Problem of High Generic Drug Costs
por: Luo, Jing, et al.
Publicado: (2015) -
Improving but unequal: Temporal trends in Chinese self-rated health, 1990–2012
por: Kwon, Soyoung, et al.
Publicado: (2016) -
Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study
por: Kesselheim, Aaron S, et al.
Publicado: (2015) -
CARD9-Mediated Signaling and Cardiovascular Diseases
por: Liu, Xuanyou, et al.
Publicado: (2022)